Literature DB >> 24733900

Selective inhibition of the function of tyrosine-phosphorylated STAT3 with a phosphorylation site-specific intrabody.

Mi Young Koo1, Jiyoung Park, Jung Mi Lim, Sei Yoon Joo, Seung-Pil Shin, Hyun Bo Shim, Junho Chung, Dongmin Kang, Hyun Ae Woo, Sue Goo Rhee.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) is a multifunctional protein that participates in signaling pathways initiated by various growth factors and cytokines. It exists in multiple forms including those phosphorylated on Tyr(705) (pYSTAT3) or Ser(727) (pSSTAT3) as well as the unphosphorylated protein (USTAT3). In addition to the canonical transcriptional regulatory role of pYSTAT3, both USTAT3 and pSSTAT3 function as transcriptional regulators by binding to distinct promoter sites and play signaling roles in the cytosol or mitochondria. The roles of each STAT3 species in different biological processes have not been readily amenable to investigation, however. We have now prepared an intrabody that binds specifically and with high affinity to the tyrosine-phosphorylated site of pYSTAT3. Adenovirus-mediated expression of the intrabody in HepG2 cells as well as mouse liver blocked both the accumulation of pYSTAT3 in the nucleus and the production of acute phase response proteins induced by interleukin-6. Intrabody expression did not affect the overall accumulation of pSSTAT3 induced by interleukin-6 or phorbol 12-myristate 13-acetate (PMA), the PMA-induced expression of the c-Fos gene, or the PMA-induced accumulation of pSSTAT3 specifically in mitochondria. In addition, it had no effect on interleukin-6-induced expression of the gene for IFN regulatory factor 1, a downstream target of STAT1. Our results suggest that the engineered intrabody is able to block specifically the downstream effects of pYSTAT3 without influencing those of pSSTAT3, demonstrating the potential of intrabodies as tools to dissect the cellular functions of specific modified forms of proteins that exist as multiple species.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733900      PMCID: PMC4035943          DOI: 10.1073/pnas.1316815111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Independent and cooperative activation of chromosomal c-fos promoter by STAT3.

Authors:  Edward Yang; Lorena Lerner; Daniel Besser; James E Darnell
Journal:  J Biol Chem       Date:  2003-02-24       Impact factor: 5.157

2.  IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.

Authors:  A Ogata; D Chauhan; G Teoh; S P Treon; M Urashima; R L Schlossman; K C Anderson
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

Review 3.  Intracellular antibodies and challenges facing their use as therapeutic agents.

Authors:  M Natividad Lobato; Terence H Rabbitts
Journal:  Trends Mol Med       Date:  2003-09       Impact factor: 11.951

Review 4.  The acute phase response.

Authors:  H Baumann; J Gauldie
Journal:  Immunol Today       Date:  1994-02

Review 5.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 6.  Endotoxins and disease mechanisms.

Authors:  D C Morrison; J L Ryan
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

7.  Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases.

Authors:  T K Sengupta; E S Talbot; P A Scherle; L B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 8.  Serine phosphorylation of STATs.

Authors:  T Decker; P Kovarik
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

9.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

10.  Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2.

Authors:  C Hodge; J Liao; M Stofega; K Guan; C Carter-Su; J Schwartz
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

View more
  17 in total

1.  ATF7 is stabilized during mitosis in a CDK1-dependent manner and contributes to cyclin D1 expression.

Authors:  Etienne Schaeffer; Marc Vigneron; Annie-Paule Sibler; Mustapha Oulad-Abdelghani; Bruno Chatton; Mariel Donzeau
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  The JAK-STAT pathway: impact on human disease and therapeutic intervention.

Authors:  John J O'Shea; Daniella M Schwartz; Alejandro V Villarino; Massimo Gadina; Iain B McInnes; Arian Laurence
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

Review 3.  Single domain antibodies for the knockdown of cytosolic and nuclear proteins.

Authors:  Thomas Böldicke
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

Review 4.  Mechanisms of Jak/STAT signaling in immunity and disease.

Authors:  Alejandro V Villarino; Yuka Kanno; John R Ferdinand; John J O'Shea
Journal:  J Immunol       Date:  2015-01-01       Impact factor: 5.422

Review 5.  Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases.

Authors:  Daniella M Schwartz; Michael Bonelli; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Rheumatol       Date:  2015-12-03       Impact factor: 20.543

6.  A phosphorylation pattern-recognizing antibody specifically reacts to RNA polymerase II bound to exons.

Authors:  Jungwon Han; Jong-Hyuk Lee; Sunyoung Park; Soomin Yoon; Aerin Yoon; Do B Hwang; Hwa K Lee; Min S Kim; Yujean Lee; Won J Yang; Hong-Duk Youn; Hyori Kim; Junho Chung
Journal:  Exp Mol Med       Date:  2016-11-18       Impact factor: 8.718

7.  Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells.

Authors:  Stefan Somplatzki; Martina Mühlenhoff; Andrea Kröger; Rita Gerardy-Schahn; Thomas Böldicke
Journal:  BMC Biotechnol       Date:  2017-05-12       Impact factor: 2.563

Review 8.  Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.

Authors:  Congcong Zhang; Rina M Ötjengerdes; Julian Roewe; Rebeca Mejias; Andrea L J Marschall
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

9.  The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure.

Authors:  Chun-Tao Lei; Hua Su; Chen Ye; Hui Tang; Pan Gao; Cheng Wan; Fang-Fang He; Yu-Mei Wang; Chun Zhang
Journal:  J Cell Mol Med       Date:  2017-09-07       Impact factor: 5.310

10.  Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer.

Authors:  Inês de Albuquerque Almeida Batista; Luisa Alejandra Helguero
Journal:  Signal Transduct Target Ther       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.